UNSPSC 51242206: Chloroxylenol/hydrocortisone/pramoxine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class OT900. This VA Drug Class (OT900) classifies this compound as belonging to the group OTIC AGENTS, OTHER.

UNSPSC 51242206 Chloroxylenol/hydrocortisone/pramoxine is a Commodity code covering specific pharmaceutical combination products distributed through state and local health facilities. State and local procurement under this code focuses on generic multi-source pharmaceuticals and over-the-counter products meeting FDA requirements, cGMP certification, and Drug Supply Chain Security Act (DSCSA) compliance. Products must be available through authorized pharmaceutical wholesalers (AmerisourceBergen Drug Corporation/Cencora, Cardinal Health 110 and 112, and Morris & Dickson Co., LLC) and supplied with complete product documentation including National Drug Codes, SKUs, UPCs, generic descriptions, strength, dosage form, and packaging configurations. Vendors must maintain chargeback systems with at least two of the three authorized wholesalers and carry comprehensive insurance including $5 million commercial general liability and $2 million network security and privacy liability coverage. Issuing bodies under this code include multistate cooperative purchasing alliances serving state departments and local government facilities.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, posted the most recent relevant opportunity (RFP S1070000015802, due March 26, 2026) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products across participating state and local government facilities in Minnesota and Oregon. Price competitiveness carries 75 percent evaluation weight, with fixed pricing, EDI capability, administrative compliance, and agreement to a 3 percent administrative fee making up the remaining 25 percent. The contract term is two years for new vendors with optional extensions at MMCAP's sole discretion, while incumbent vendor amendments extend through June 30, 2028. Products must be available in the marketplace by May 15, 2026, with awarded vendor agreements effective July 1, 2026.